399.15MMarket Cap-9487P/E (TTM)
27.610High24.230Low1.33MVolume25.970Open22.315Pre Close34.68MTurnover20.11%Turnover RatioLossP/E (Static)14.85MShares74.49052wk High2.90P/B178.02MFloat Cap12.49052wk Low--Dividend TTM6.63MShs Float1115.000Historical High--Div YieldTTM15.15%Amplitude7.500Historical Low26.026Avg Price1Lot Size
Neurogene Stock Forum
This Will continue to drive downward. And after you finally sell your position for a loss, they will buy back. Follow the money
📊⚡️📊
NEWS
Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
NEW YORK--(BUSINESS WIRE)-- Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that initial safety and tolerability data from its ongoing Phase 1/2 gene therapy clinical trial for Rett syndrome will be ...
No comment yet